📣 VC round data is live. Check it out!
- Public Comps
- Weed
Weed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Weed and similar public comparables like Pineapple, Dogecoin Cash, Aion Therapeutic, Ayr Wellness and more.
Weed Overview
About Weed
Weed Inc is working on or planning for several different business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations, and harvest for research, product development, processing, and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a basis for both the Medical Cannabis and Hemp international market space.
Founded
1999
HQ

Employees
2
Website
Financials (FY)
EV
$5M
Valuation Multiples
Start free trialWeed Financials
Weed reported last fiscal year revenue of — and negative EBITDA of ($1M).
In the same fiscal year, Weed generated — in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).
Weed P&L
In the most recent fiscal year, Weed reported revenue of — and EBITDA of ($1M).
Weed is unprofitable as of last fiscal year, with gross margin of —, EBITDA margin of —, and net margin of —.
Financial data powered by Morningstar, Inc.
Weed Stock Performance
Weed has current market cap of $5M, and enterprise value of $5M.
Weed's stock price is $0.03.
Weed has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $5M | 0.0% | — | — | — | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWeed Valuation Multiples
Weed trades at (4.2x) EV/EBITDA.
Weed Financial Valuation Multiples
As of May 10, 2026, Weed has market cap of $5M and EV of $5M.
Weed has a P/E ratio of (3.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Weed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Weed Margins & Growth Rates
Weed Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Weed Operational KPIs
Weed's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.7M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Weed Competitors
Weed competitors include Pineapple, Dogecoin Cash, Aion Therapeutic, Ayr Wellness, Pharmadrug, Neon Bloom, RAMM Pharma, 1606, Humanoid Global Holdings and The Cannabist Company.
Most Weed public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | (8.6x) | — | |||
| 3.4x | — | (0.3x) | — | |||
| 14.4x | — | (0.9x) | — | |||
| 1.3x | — | (3.9x) | — | |||
| — | — | (6.4x) | — | |||
| — | — | — | — | |||
| 0.1x | — | (0.0x) | — | |||
| — | — | (5.1x) | — | |||
This data is available for Pro users. Sign up to see all Weed competitors and their valuation data. Start Free Trial | ||||||
Weed M&A Activity
Weed has acquired 1 company to date.
Last acquisition by Weed was on July 20th 2022. Weed acquired Hempirical Genetics for $800K (EV/Revenue multiple of ).
Latest Acquisitions by Weed
| Description | Hempirical Genetics is a cannabis cultivator focused on breeding varieties for therapeutic compounds. The firm develops strains targeting pain and inflammation for human and veterinary pharmaceuticals. |
| HQ Country | |
| HQ City | Huachuca City, AZ |
| Deal Date | 20 Jul 2022 |
| Valuation | $800K |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Weed acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Weed
| When was Weed founded? | Weed was founded in 1999. |
| Where is Weed headquartered? | Weed is headquartered in United States. |
| How many employees does Weed have? | As of today, Weed has over 2 employees. |
| Is Weed publicly listed? | Yes, Weed is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Weed? | Weed trades under BUDZ ticker. |
| When did Weed go public? | Weed went public in 2009. |
| Who are competitors of Weed? | Weed main competitors include Pineapple, Dogecoin Cash, Aion Therapeutic, Ayr Wellness, Pharmadrug, Neon Bloom, RAMM Pharma, 1606, Humanoid Global Holdings, The Cannabist Company. |
| What is the current market cap of Weed? | Weed's current market cap is $5M. |
| Is Weed profitable? | No, Weed is not profitable. |
| How many companies Weed has acquired to date? | As of May 2026, Weed has acquired 1 company. |
| What was the largest acquisition by Weed? | $800K acquisition of Hempirical Genetics on 20th July 2022 was the largest M&A Weed has done to date. |
| What companies Weed acquired? | Weed acquired Hempirical Genetics. |
| In how many companies Weed has invested to date? | Weed hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Weed
Lists including Weed
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
